FindTrial
Sign In

A study of efficacy and safety in sedation and analgesia of dexmedetomidine combined with remifentanil

A study of efficacy and safety in sedation and analgesia of dexmedetomidine combined with remifentanil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027958
Enrollment
Unknown
Registered
2019-12-07
Start date
2019-12-05
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fat accumulation

Interventions

A1:Dexmedetomidine continuous infusion
A2:Continuous infusion after dexmedetomidine loading dose
B1:Early heart rate without intervention
B2:Early heart rate intervention

Sponsors

Plastic Surgery Hospital, CAMS, PUMC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged from 18-55 years; 2.No limit on the gender; 3.American Society of Anesthesiologists physical status I or II; 4.Scheduled for elective plastic operations under sedative and analgesic anesthesia; 5.Written conformed content.

Exclusion criteria

Exclusion criteria: 1.Suffering from organic congenital heart disease or arrhythmia, hypertension; 2.Have liver and kidney disease; 3.Body mass index >= 30; 4.Have a history of epilepsy and are currently taking medication; 5.Mentally unhealthy patient.

Design outcomes

Primary

MeasureTime frame
Heart rate;Blood Pressure;Respiratory rate;Bispectral index;—

Secondary

MeasureTime frame
Ramsay sedation scores;Pain index;—

Countries

China

Contacts

Public ContactXiaoming Deng

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

dengxiaoming2003@sina.com+86 13611005236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026